Product Overview
Compounded Oral Semaglutide is a GLP-1 receptor agonist provided in oral form for patients seeking a non-injectable option to support metabolic and appetite regulation.
How It Works
Oral semaglutide activates the GLP-1 receptor to reduce appetite, slow gastric emptying, and enhance glucose-dependent insulin secretion. These effects support blood sugar regulation and appetite control.
Safety Information
This medication may not be appropriate for all individuals.
Do not use if you have:
- A personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Consult a healthcare provider before use if you have:
- A history of pancreatitis
- Gallbladder disease
- Kidney disease or dehydration
- Severe gastrointestinal disorders
- Diabetic retinopathy
- A history of thyroid disease
Delayed gastric emptying may impact the absorption of other oral medications.
Risk of hypoglycemia may increase when combined with insulin or insulin-stimulating medications.
Common Side Effects
Commonly reported side effects may include:
Nausea
Vomiting
Diarrhea
Constipation
Abdominal discomfort
Decreased appetite
Fatigue
Headache
Dizziness
Serious adverse reactions may include pancreatitis, gallbladder complications, kidney injury, or severe gastrointestinal symptoms.
Compounding Disclosure
This medication is compounded by a licensed pharmacy and is not FDA-approved. It is prepared based on a healthcare provider’s prescription.